Developer docs
API playgroundTry for free, no card

Search company profiles

HumanOptics

Full company profile

uuid003f939

Namestring
HumanOptics
Legal namestring
HumanOptics Holding AG
Websiteurl
humanoptics.com
Company typeenum
Private
Founded yearint
1985
Descriptiontext

HumanOptics Holding AG is a German medical device manufacturer specializing in premium intraocular implants for ophthalmic surgery, headquartered in Erlangen with a secondary manufacturing facility in Sankt Augustin. Its core products comprise a full intraocular lens (IOL) portfolio — including monofocal lenses (ASPIRA/-aA, the 2026-launched ASPIRA-aAY+ enhanced monofocal, and ASPIRA-aXA with 7.0mm XL optics), toric lenses (TORICA), and trifocal/trifocal-toric lenses (TRIVA, TRIVA T) — alongside the ARTIFICIALIRIS platform of custom (CUSTOMFLEX) and pre-defined color (SELECT) foldable silicone iris prostheses for aniridia treatment. CUSTOMFLEX is the only artificial iris with both FDA approval and CE marking; all manufacturing takes place in Germany under TÜV-certified EN ISO 13485 and EU MDR quality systems, with multiple 100% quality checks.

The company sells one-time implantable devices directly to eye surgeons and ophthalmology clinics through a dedicated enterprise field sales force with territory managers, supported by a Sales Partner Portal and Customer Service ordering channels, and participates in major ophthalmology congresses (DOC, ESCRS, DOG, APAO). CUSTOMFLEX requires surgeons to complete an Online Certification Course before ordering, functioning as a training and gating mechanism, and the company distributes accessories including surgical knives, injectors with the Safeloader preloaded system, viscoelastic solutions, capsule tension rings, trephines, and forceps. Reimbursement has been secured in the United States (2018) and France (2019) for ARTIFICIALIRIS CUSTOMFLEX.

HumanOptics serves a horizontal customer base of hospital- and clinic-based eye surgeons treating cataract patients (the most common surgery in Germany, performed up to 800,000 times annually), patients with astigmatism or presbyopia, and the narrower aniridia and iris-defect population, with more than 7,500 ARTIFICIALIRIS implantations performed worldwide since the first implantation in 2002. The firm is represented in over 40 countries across EMEA, North America, Asia-Pacific, and the Middle East, with stated leadership comprising CEO Alexander Berka and Supervisory Board Chair Yuan Yuan under a German Aktiengesellschaft governance structure.

Short descriptiontext

HumanOptics Holding AG is a German manufacturer of premium intraocular lenses (ASPIRA, TORICA, TRIVA) and ARTIFICIALIRIS custom and pre-defined iris implants, selling directly to eye surgeons and ophthalmology clinics across 40+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersErlangen, Germany
HQ citystring
Erlangen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
premium intraocular lenses, artificial iris implants, ophthalmic medical devices, cataract surgery implants, aniridia treatment
Industry1 code
PRIMARYHLAHAJAH
Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
NAICS code2 codes
  • Ophthalmic Goods Manufacturing339115
  • Surgical Appliance and Supplies Manufacturing339113
SIC code3 codes
  • Ophthalmic Goods3851
  • Surgical & Medical Instruments & Apparatus3841
  • Optical Instruments & Lenses3827
Product category
Ophthalmic Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Intraocular Lens Sales
TypeOne Time License
Description

Sale of premium IOLs including monofocal (ASPIRA, TORICA), trifocal (TRIVA), and XL optic variants. One-time implantable medical devices sold directly to eye surgeons and hospitals.

humanoptics.com
2Artificial Iris Implant Sales
TypeOne Time License
Description

Sale of custom (CUSTOMFLEX) and standardized (SELECT) artificial iris implants. Both models are foldable silicone iris prostheses for aniridia treatment, requiring surgeon certification for purchase.

humanoptics.com
3Surgical Accessories
TypeOne Time License
Description

Sale of surgical accessories including disposable knives, injectors, viscoelastic solutions, OP sets, trephines, tweezers, and capsular tension rings for ophthalmic procedures.

humanoptics.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1ASPIRA
Description

Monofocal intraocular lens platform with extended delivery range, includes ASPIRA-aA, ASPIRA-aAY, and ASPIRA-aAY+ variants

humanoptics.com
+10 more records
Core offering1 text field

HumanOptics develops, manufactures, and distributes premium intraocular implants for eye surgery, including a complete portfolio of intraocular lenses (IOLs) — monofocal (ASPIRA, ASPIRA-aXA, ASPIRA-aAY+), toric (TORICA), and trifocal/trifocal-toric (TRIVA, TRIVA T) — along with the world's only FDA-approved and CE-marked custom artificial iris implant (ARTIFICIALIRIS CUSTOMFLEX) and a stock-color variant (ARTIFICIALIRIS SELECT). All products are 100% manufactured in Germany at TÜV-certified facilities and sold to eye surgeons, hospitals, and clinics through direct field sales across 40+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 95% of customers trust the expertise of HumanOptics' application team
+4 more records
Product overview1 text field

HumanOptics is a German manufacturer of premium eye surgery implants offering a comprehensive intraocular lens (IOL) portfolio and the world's unique artificial iris platform. The IOL portfolio includes monofocal lenses (ASPIRA®/-aA, ASPIRA®-aAY+ enhanced monofocal, ASPIRA®-aXA with XL 7.0mm optics), toric lenses (TORICA®), and trifocal/trifocal-toric lenses (TRIVA®, TRIVA® T). The ARTIFICIALIRIS platform provides custom (CUSTOMFLEX® - FDA-approved and CE-marked) and predefined color (SELECT) iris implants for aniridia treatment. Supporting accessories include surgical knives, injectors with Safeloader® preloaded system, viscoelastic solutions, capsule tension rings, and trephines. All products are 100% manufactured in Germany at TÜV-certified facilities.

Product and service13 records
1ASPIRA® / -aA Monofocal IOL
CategoryIntraocular Lens (Monofocal)
Description

Monofocal intraocular lens platform featuring aspheric aberration-free optics, 360° lens epithelial cell barrier, and hydrophilic acrylic material with 26% water content at 35°C. XL delivery range from -20.0 to +60.0 dpt. Indicated for cataract surgery and refractive lens exchange, sold to eye surgeons and hospitals.

2ASPIRA®-aAY+ Enhanced Monofocal IOL
CategoryIntraocular Lens (Enhanced Monofocal)
Description

New-generation enhanced monofocal IOL with optimized aspheric optics extending light distribution toward the intermediate range, improving subjective depth of field while maintaining distance visual quality. Fully refractive design with dysphotopsia profile comparable to conventional monofocal IOLs. Available in 0.5 dpt and 1.0 dpt steps with diopter range 0.0-30.0 dpt.

3ASPIRA®-aXA XL-Optic Monofocal IOL
CategoryIntraocular Lens (XL Monofocal)
Description

Monofocal IOL with enlarged 7.0 mm optic diameter for improved fundus periphery visualization, effective dysphotopsia reduction, and excellent capsular bag stability via Quattor-Point positioning. Indicated for patients with wide pupils, traumatic mydriasis, iris defects, increased retinal disease risk, or combined vitreoretinal surgery.

4TORICA® Toric IOL
CategoryIntraocular Lens (Toric)
Description

Toric monofocal intraocular lens for corneal astigmatism correction, available in XL delivery range with cylinder power up to 20.0 dpt. Features aspheric aberration-free optics with omnidirectional aberration correction, indicated for cataract patients with pre-existing astigmatism.

5TRIVA® Trifocal IOL
CategoryIntraocular Lens (Trifocal)
Description

Trifocal intraocular lens providing continuous near-to-far vision through full vision range optics. Features balanced light distribution across all pupil diameters with near addition +3.5 dpt and intermediate addition +1.75 dpt. 92-100% of patients achieve spectacle independence across distance, intermediate, and near vision.

6TRIVA® T Trifocal-Toric IOL
CategoryIntraocular Lens (Trifocal-Toric)
Description

Trifocal-toric intraocular lens combining trifocal optics with astigmatism correction. Indicated for patients with corneal astigmatism from 1.0 dpt, with cylinder range 1.0 to 6.0 dpt.

7ARTIFICIALIRIS CUSTOMFLEX® Custom Iris Implant
CategoryArtificial Iris Implant (Custom)
Description

World's only FDA-approved and CE-marked custom iris implant for complete or partial aniridia treatment. Handmade in Germany from biocompatible foldable silicone, individually color-matched to the patient's natural iris from a photo template. Features 3D-structured surface, 12.8 mm total diameter, fixed 3.35 mm pupil opening, and 100% light absorption on the black backside. Over 7,500 implantations performed worldwide since 2002. Requires surgeon certification via the Online Certification Course before ordering.

8ARTIFICIALIRIS SELECT Standard Iris Implant
CategoryArtificial Iris Implant (Standard)
Description

Pre-defined color artificial iris implant available from stock in nine color combinations (brown, blue, green in light, medium, and dark shades) for rapid patient care. Same technical specifications as CUSTOMFLEX including 12.8 mm diameter, foldable silicone, and 100% light absorption, with simplified ordering and shorter lead times.

9Surgical Disposable Knives
CategoryOphthalmic Surgical Accessory
Description

Extra sharp disposable ophthalmic surgical knives including Slit Knife (SMART Shape design, 0.12-0.14 mm blade), Straight Knife (15°-45° angles), MVR Knife (19g-24g), Crescent Knife, R Slit Knife, and Pterygium Knife. Color-coded by application with ergonomic plastic handles for cataract and refractive procedures.

10Injectors & Safeloader® Preloaded Implantation System
CategoryOphthalmic Surgical Accessory
Description

Medicel AccuJect™ injectors with yellow plunger compatible with all HumanOptics IOL models. Safeloader® is a touch-free preloaded implantation system offering precise IOL delivery through separate IOL and injector sterilization. Supports XS incisions ≥1.8 mm for extreme diopter ranges up to 60.0 dpt.

11Viscoelastic Solutions
CategoryOphthalmic Surgical Accessory
Description

Pe-Ha-Visco® (2.0%/2.4% hydroxypropylmethylcellulose) and Pe-Ha-Luron® F (1.4%/1.8%/2.2% sodium hyaluronate from biofermentation) viscoelastic solutions for anterior chamber stabilization and endothelial tissue protection during ophthalmic surgery.

12Capsule Tension Rings (CTR)
CategoryOphthalmic Surgical Accessory
Description

Capsule stabilizing rings for damaged or missing zonular fibers. Available in preloaded EyeJet® CTR models (13A, 14A, 14C, 20C) and non-preloaded versions. Sizes range from 12.0-14.5 mm in blue PMMA or clear PMMA materials.

13Trephines & Forceps
CategoryOphthalmic Surgical Accessory
Description

Ophthalmological punch instruments for patient-individual sizing of ARTIFICIALIRIS implants. Trephines available in 8.0-12.5 mm diameters with 0.25-0.5 mm steps. Re-sterilizable forceps including angulated lens-folding forceps and crossed rounded implantation forceps.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Sells a broad premium IOL portfolio (enVista, LuxSmart, Crystalens) competing with HumanOptics across monofocal, toric, and presbyopia-correcting categories in cataract surgery.

2Santen Pharmaceutical
TypeBroad incumbent
Description

Japanese ophthalmology specialist with a growing surgical portfolio (including IOLs) and broad presence across Europe and Asia, comparable as a regional heavyweight competing for the same surgeon channel.

TypeDirect peer
Description

European (Hungarian/Czech) IOL specialist with preloaded monofocal, toric, and trifocal lenses (Precizon). Comparable mid-sized specialty IOL manufacturer competing in the same surgeon channel as HumanOptics.

TypeBroad incumbent
Description

Global leader in ophthalmic surgery including premium IOLs (PanOptix trifocal, Vivity). Competes directly with HumanOptics' ASPIRA, TORICA, and TRIVA trifocal IOL portfolios in cataract and refractive surgery.

TypeDirect peer
Description

Dutch specialist in iris reconstruction and premium IOLs (including Artisan/Verisyse iris-fixated lenses). The closest direct competitor to HumanOptics' ARTIFICIALIRIS franchise in iris defect surgery.

TypeBroad incumbent
Description

Markets the TECNIS IOL family (monofocal, toric, multifocal) and competes directly with HumanOptics in premium cataract surgery, including the trifocal/enhanced monofocal segments where TRIVA and ASPIRA-aAY+ play.

TypeDirect peer
Description

Specialist IOL manufacturer offering preloaded and toric/trifocal IOLs (Vivinex, Toric). Directly comparable to HumanOptics in the premium IOL segment with similar surgeon-targeted specialty positioning.

TypeEmerging player
Description

Japanese ophthalmic equipment and surgical device maker with IOL and surgical microscope offerings; competes with HumanOptics particularly in Asia-Pacific markets where both companies have direct presence.

TypeDirect peer
Description

UK-based premium IOL manufacturer with monofocal, toric (RayOne), and trifocal (RayOne Trifocal) products. Directly comparable mid-sized specialty IOL peer to HumanOptics.

10Carl Zeiss Meditec
TypeBroad incumbent
Description

Markets premium cataract surgical microscopes and IOLs (CT LUCIA, CT SPHERIS). Competes with HumanOptics in the premium IOL segment and shares a German manufacturing heritage.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HumanOptics

Ophthalmic Medical Deviceshumanoptics.com

HumanOptics Holding AG is a German manufacturer of premium intraocular lenses (ASPIRA, TORICA, TRIVA) and ARTIFICIALIRIS custom and pre-defined iris implants, selling directly to eye surgeons and ophthalmology clinics across 40+ countries.

What HumanOptics does

HumanOptics Holding AG is a German medical device manufacturer specializing in premium intraocular implants for ophthalmic surgery, headquartered in Erlangen with a secondary manufacturing facility in Sankt Augustin. Its core products comprise a full intraocular lens (IOL) portfolio — including monofocal lenses (ASPIRA/-aA, the 2026-launched ASPIRA-aAY+ enhanced monofocal, and ASPIRA-aXA with 7.0mm XL optics), toric lenses (TORICA), and trifocal/trifocal-toric lenses (TRIVA, TRIVA T) — alongside the ARTIFICIALIRIS platform of custom (CUSTOMFLEX) and pre-defined color (SELECT) foldable silicone iris prostheses for aniridia treatment. CUSTOMFLEX is the only artificial iris with both FDA approval and CE marking; all manufacturing takes place in Germany under TÜV-certified EN ISO 13485 and EU MDR quality systems, with multiple 100% quality checks.

The company sells one-time implantable devices directly to eye surgeons and ophthalmology clinics through a dedicated enterprise field sales force with territory managers, supported by a Sales Partner Portal and Customer Service ordering channels, and participates in major ophthalmology congresses (DOC, ESCRS, DOG, APAO). CUSTOMFLEX requires surgeons to complete an Online Certification Course before ordering, functioning as a training and gating mechanism, and the company distributes accessories including surgical knives, injectors with the Safeloader preloaded system, viscoelastic solutions, capsule tension rings, trephines, and forceps. Reimbursement has been secured in the United States (2018) and France (2019) for ARTIFICIALIRIS CUSTOMFLEX.

HumanOptics serves a horizontal customer base of hospital- and clinic-based eye surgeons treating cataract patients (the most common surgery in Germany, performed up to 800,000 times annually), patients with astigmatism or presbyopia, and the narrower aniridia and iris-defect population, with more than 7,500 ARTIFICIALIRIS implantations performed worldwide since the first implantation in 2002. The firm is represented in over 40 countries across EMEA, North America, Asia-Pacific, and the Middle East, with stated leadership comprising CEO Alexander Berka and Supervisory Board Chair Yuan Yuan under a German Aktiengesellschaft governance structure.

HumanOptics firmographics

Firmographics
Name
HumanOptics
Legal name
HumanOptics Holding AG
Website
https://humanoptics.com
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
51–100 employees
Short description
HumanOptics Holding AG is a German manufacturer of premium intraocular lenses (ASPIRA, TORICA, TRIVA) and ARTIFICIALIRIS custom and pre-defined iris implants, selling directly to eye surgeons and ophthalmology clinics across 40+ countries.
Ownership category
akta.pro rank

HumanOptics industry classification

Industry
Product category
Ophthalmic Medical Devices
NAICS
Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
akta.pro industry
PRIMARYHLAHAJAH
Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

  • Premium intraocular lenses
  • Artificial iris implants
  • Ophthalmic medical devices
  • Cataract surgery implants
  • Aniridia treatment

Where HumanOptics is headquartered

Location

Headquarters

HQ city
Erlangen
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

HumanOptics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Intraocular Lens Sales: Sale of premium IOLs including monofocal (ASPIRA, TORICA), trifocal (TRIVA), and XL optic variants. One-time implantable medical devices sold directly to eye surgeons and hospitals.
  2. Artificial Iris Implant Sales: Sale of custom (CUSTOMFLEX) and standardized (SELECT) artificial iris implants. Both models are foldable silicone iris prostheses for aniridia treatment, requiring surgeon certification for purchase.
  3. Surgical Accessories: Sale of surgical accessories including disposable knives, injectors, viscoelastic solutions, OP sets, trephines, tweezers, and capsular tension rings for ophthalmic procedures.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

HumanOptics product offering

Product offering

Core offering

HumanOptics develops, manufactures, and distributes premium intraocular implants for eye surgery, including a complete portfolio of intraocular lenses (IOLs) — monofocal (ASPIRA, ASPIRA-aXA, ASPIRA-aAY+), toric (TORICA), and trifocal/trifocal-toric (TRIVA, TRIVA T) — along with the world's only FDA-approved and CE-marked custom artificial iris implant (ARTIFICIALIRIS CUSTOMFLEX) and a stock-color variant (ARTIFICIALIRIS SELECT). All products are 100% manufactured in Germany at TÜV-certified facilities and sold to eye surgeons, hospitals, and clinics through direct field sales across 40+ countries.

Product overview

HumanOptics is a German manufacturer of premium eye surgery implants offering a comprehensive intraocular lens (IOL) portfolio and the world's unique artificial iris platform. The IOL portfolio includes monofocal lenses (ASPIRA®/-aA, ASPIRA®-aAY+ enhanced monofocal, ASPIRA®-aXA with XL 7.0mm optics), toric lenses (TORICA®), and trifocal/trifocal-toric lenses (TRIVA®, TRIVA® T). The ARTIFICIALIRIS platform provides custom (CUSTOMFLEX® - FDA-approved and CE-marked) and predefined color (SELECT) iris implants for aniridia treatment. Supporting accessories include surgical knives, injectors with Safeloader® preloaded system, viscoelastic solutions, capsule tension rings, and trephines. All products are 100% manufactured in Germany at TÜV-certified facilities.

Differentiator

Problem solved

Functional benefit

Brands

  • ASPIRA: Monofocal intraocular lens platform with extended delivery range, includes ASPIRA-aA, ASPIRA-aAY, and ASPIRA-aAY+ variants
  • TORICA
  • TRIVA
  • TRIVA T
  • ASPIRA aXA
  • ASPIRA aAY+
  • ARTIFICIALIRIS CUSTOMFLEX
  • ARTIFICIALIRIS SELECT
  • Safeloader
  • Pe-Ha-Visco
  • Pe-Ha-Luron F

Products and services

  • ASPIRA® / -aA Monofocal IOL Monofocal intraocular lens platform featuring aspheric aberration-free optics, 360° lens epithelial cell barrier, and hydrophilic acrylic material with 26% water content at 35°C. XL delivery range from -20.0 to +60.0 dpt. Indicated for cataract surgery and refractive lens exchange, sold to eye surgeons and hospitals.
  • ASPIRA®-aAY+ Enhanced Monofocal IOL New-generation enhanced monofocal IOL with optimized aspheric optics extending light distribution toward the intermediate range, improving subjective depth of field while maintaining distance visual quality. Fully refractive design with dysphotopsia profile comparable to conventional monofocal IOLs. Available in 0.5 dpt and 1.0 dpt steps with diopter range 0.0-30.0 dpt.
  • ASPIRA®-aXA XL-Optic Monofocal IOL Monofocal IOL with enlarged 7.0 mm optic diameter for improved fundus periphery visualization, effective dysphotopsia reduction, and excellent capsular bag stability via Quattor-Point positioning. Indicated for patients with wide pupils, traumatic mydriasis, iris defects, increased retinal disease risk, or combined vitreoretinal surgery.
  • TORICA® Toric IOL Toric monofocal intraocular lens for corneal astigmatism correction, available in XL delivery range with cylinder power up to 20.0 dpt. Features aspheric aberration-free optics with omnidirectional aberration correction, indicated for cataract patients with pre-existing astigmatism.
  • TRIVA® Trifocal IOL Trifocal intraocular lens providing continuous near-to-far vision through full vision range optics. Features balanced light distribution across all pupil diameters with near addition +3.5 dpt and intermediate addition +1.75 dpt. 92-100% of patients achieve spectacle independence across distance, intermediate, and near vision.
  • TRIVA® T Trifocal-Toric IOL Trifocal-toric intraocular lens combining trifocal optics with astigmatism correction. Indicated for patients with corneal astigmatism from 1.0 dpt, with cylinder range 1.0 to 6.0 dpt.
  • ARTIFICIALIRIS CUSTOMFLEX® Custom Iris Implant World's only FDA-approved and CE-marked custom iris implant for complete or partial aniridia treatment. Handmade in Germany from biocompatible foldable silicone, individually color-matched to the patient's natural iris from a photo template. Features 3D-structured surface, 12.8 mm total diameter, fixed 3.35 mm pupil opening, and 100% light absorption on the black backside. Over 7,500 implantations performed worldwide since 2002. Requires surgeon certification via the Online Certification Course before ordering.
  • ARTIFICIALIRIS SELECT Standard Iris Implant Pre-defined color artificial iris implant available from stock in nine color combinations (brown, blue, green in light, medium, and dark shades) for rapid patient care. Same technical specifications as CUSTOMFLEX including 12.8 mm diameter, foldable silicone, and 100% light absorption, with simplified ordering and shorter lead times.
  • Surgical Disposable Knives Extra sharp disposable ophthalmic surgical knives including Slit Knife (SMART Shape design, 0.12-0.14 mm blade), Straight Knife (15°-45° angles), MVR Knife (19g-24g), Crescent Knife, R Slit Knife, and Pterygium Knife. Color-coded by application with ergonomic plastic handles for cataract and refractive procedures.
  • Injectors & Safeloader® Preloaded Implantation System Medicel AccuJect™ injectors with yellow plunger compatible with all HumanOptics IOL models. Safeloader® is a touch-free preloaded implantation system offering precise IOL delivery through separate IOL and injector sterilization. Supports XS incisions ≥1.8 mm for extreme diopter ranges up to 60.0 dpt.
  • Viscoelastic Solutions Pe-Ha-Visco® (2.0%/2.4% hydroxypropylmethylcellulose) and Pe-Ha-Luron® F (1.4%/1.8%/2.2% sodium hyaluronate from biofermentation) viscoelastic solutions for anterior chamber stabilization and endothelial tissue protection during ophthalmic surgery.
  • Capsule Tension Rings (CTR) Capsule stabilizing rings for damaged or missing zonular fibers. Available in preloaded EyeJet® CTR models (13A, 14A, 14C, 20C) and non-preloaded versions. Sizes range from 12.0-14.5 mm in blue PMMA or clear PMMA materials.
  • Trephines & Forceps Ophthalmological punch instruments for patient-individual sizing of ARTIFICIALIRIS implants. Trephines available in 8.0-12.5 mm diameters with 0.25-0.5 mm steps. Re-sterilizable forceps including angulated lens-folding forceps and crossed rounded implantation forceps.

Quantifiable outcome

  • 95% of customers trust the expertise of HumanOptics' application team
  • +4 more outcomes

Companies that use HumanOptics

Customer profile

Segments3 records

Ideal customer profiles2 records

HumanOptics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

HumanOptics partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

HumanOptics competitors and assessment

Company assessment

Broad incumbents

  • Bausch + Lomb: Sells a broad premium IOL portfolio (enVista, LuxSmart, Crystalens) competing with HumanOptics across monofocal, toric, and presbyopia-correcting categories in cataract surgery.
  • Santen Pharmaceutical: Japanese ophthalmology specialist with a growing surgical portfolio (including IOLs) and broad presence across Europe and Asia, comparable as a regional heavyweight competing for the same surgeon channel.
  • Alcon: Global leader in ophthalmic surgery including premium IOLs (PanOptix trifocal, Vivity). Competes directly with HumanOptics' ASPIRA, TORICA, and TRIVA trifocal IOL portfolios in cataract and refractive surgery.
  • Johnson & Johnson Vision: Markets the TECNIS IOL family (monofocal, toric, multifocal) and competes directly with HumanOptics in premium cataract surgery, including the trifocal/enhanced monofocal segments where TRIVA and ASPIRA-aAY+ play.
  • Carl Zeiss Meditec: Markets premium cataract surgical microscopes and IOLs (CT LUCIA, CT SPHERIS). Competes with HumanOptics in the premium IOL segment and shares a German manufacturing heritage.

Direct peers

  • Medicontur: European (Hungarian/Czech) IOL specialist with preloaded monofocal, toric, and trifocal lenses (Precizon). Comparable mid-sized specialty IOL manufacturer competing in the same surgeon channel as HumanOptics.
  • Ophtec: Dutch specialist in iris reconstruction and premium IOLs (including Artisan/Verisyse iris-fixated lenses). The closest direct competitor to HumanOptics' ARTIFICIALIRIS franchise in iris defect surgery.
  • HOYA Surgical Optics: Specialist IOL manufacturer offering preloaded and toric/trifocal IOLs (Vivinex, Toric). Directly comparable to HumanOptics in the premium IOL segment with similar surgeon-targeted specialty positioning.
  • Rayner Intraocular Lenses: UK-based premium IOL manufacturer with monofocal, toric (RayOne), and trifocal (RayOne Trifocal) products. Directly comparable mid-sized specialty IOL peer to HumanOptics.

Emerging players

  • Nidek: Japanese ophthalmic equipment and surgical device maker with IOL and surgical microscope offerings; competes with HumanOptics particularly in Asia-Pacific markets where both companies have direct presence.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

HumanOptics social profiles

Digital presence

HumanOptics compliance and trust

Trust signal

Compliance3 records

HumanOptics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HumanOptics leadership team

Management profile

Number of profiles

Profiles5 records

HumanOptics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HumanOptics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HumanOptics

What does HumanOptics do?

HumanOptics develops, manufactures, and distributes premium intraocular implants for eye surgery, including a complete portfolio of intraocular lenses (IOLs) — monofocal (ASPIRA, ASPIRA-aXA, ASPIRA-aAY+), toric (TORICA), and trifocal/trifocal-toric (TRIVA, TRIVA T) — along with the world's only FDA-approved and CE-marked custom artificial iris implant (ARTIFICIALIRIS CUSTOMFLEX) and a stock-color variant (ARTIFICIALIRIS SELECT). All products are 100% manufactured in Germany at TÜV-certified facilities and sold to eye surgeons, hospitals, and clinics through direct field sales across 40+ countries.

Is HumanOptics a public or private company?

HumanOptics is a private company. It is classified as public and is currently operating.

When was HumanOptics founded?

HumanOptics was founded in 1985. It employs 51 to 100 people.

Where is HumanOptics based?

HumanOptics is headquartered in Erlangen, Germany, in the Europe region.

How does HumanOptics make money?

Three revenue lines are on record. Intraocular Lens Sales are the primary driver. The others are artificial Iris Implant Sales and surgical Accessories.

Who are HumanOptics's main competitors?

Broad incumbents on record are Bausch + Lomb, Santen Pharmaceutical, Alcon, Johnson & Johnson Vision and Carl Zeiss Meditec. Direct peers are Medicontur, Ophtec, HOYA Surgical Optics and Rayner Intraocular Lenses. Nidek is listed as an emerging player.

Does HumanOptics have an API?

No public API is recorded for HumanOptics.

What industry is HumanOptics in?

HumanOptics's product category is Ophthalmic Medical Devices. Its primary akta.pro industry code is HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics). Its NAICS code is 339115 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comTrends in Growth, Segment Analysis, and Competitive Strategies Influencing the Ocular Implants MarketThe ocular implants market is projected to reach $27.69 billion by 2030, growing at a compound annual growth rate of 11.1%, driven by advances in technology, increasing demand for vision correction procedures, and developments in ophthalmic biomaterials. In June 2024, ANI Pharmaceuticals, Inc. acquired Alimera Sciences, Inc. to strengthen its ophthalmology portfolio with intravitreal implants Iluvien and Yutiq, while in August 2023, HumanOptics Holding AG launched its ARTIFICIALIRIS SELECT premium iris implant product.openPR.comAniridia Implant Market Analysis Report: History and Forecast 2026QYResearch published a market analysis report forecasting the global Aniridia Implant market to grow from US$ 105 million in 2024 to US$ 210 million by 2031, representing a CAGR of 10.2%. The report details market segmentation by type, application, and region, while profiling key industry players such as HumanOptics AG and Morcher GmbH.PR NewswireFDA approves first artificial irisThe FDA approved the CustomFlex Artificial Iris on May 30, 2018, making it the first stand-alone prosthetic iris approved in the United States for treating adults and children with congenital aniridia or other iris defects. The device, made by HumanOptics AG, is a custom-sized prosthetic iris made of medical-grade silicone that demonstrated strong clinical trial results with over 70 percent of 389 patients reporting decreased light sensitivity and 94 percent satisfied with cosmetic appearance. The approval was granted through the FDA's premarket approval process and received Breakthrough Device designation, reflecting its significance as a novel treatment option for a rare genetic condition affecting approximately 1 in 50,000 to 100,000 people.